A detailed history of Uss Investment Management LTD transactions in Incyte Corp stock. As of the latest transaction made, Uss Investment Management LTD holds 77,938 shares of INCY stock, worth $5.15 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
77,938
Previous 75,306 3.5%
Holding current value
$5.15 Million
Previous $4.29 Million 10.12%
% of portfolio
0.04%
Previous 0.04%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$51.18 - $63.75 $134,705 - $167,790
2,632 Added 3.5%
77,938 $4.72 Million
Q1 2024

May 15, 2024

BUY
$56.55 - $66.59 $477,168 - $561,886
8,438 Added 12.62%
75,306 $4.29 Million
Q4 2023

Feb 14, 2024

BUY
$52.16 - $64.19 $11,892 - $14,635
228 Added 0.34%
66,868 $4.2 Million
Q3 2023

Nov 14, 2023

BUY
$57.77 - $65.93 $871,056 - $994,092
15,078 Added 29.24%
66,640 $3.85 Million
Q1 2023

May 12, 2023

BUY
$70.23 - $86.01 $356,417 - $436,500
5,075 Added 10.92%
51,562 $3.73 Million
Q3 2022

Nov 08, 2022

SELL
$66.18 - $82.86 $729,237 - $913,034
-11,019 Reduced 19.16%
46,487 $3.1 Million
Q2 2022

Aug 12, 2022

SELL
$66.18 - $83.18 $184,708 - $232,155
-2,791 Reduced 4.63%
57,506 $4.37 Million
Q1 2022

May 13, 2022

BUY
$66.02 - $79.71 $1.26 Million - $1.52 Million
19,027 Added 46.1%
60,297 $4.79 Million
Q3 2021

Nov 15, 2021

BUY
$68.67 - $84.02 $2.05 Million - $2.51 Million
29,881 Added 262.37%
41,270 $2.84 Million
Q2 2020

Aug 11, 2020

BUY
$74.18 - $108.93 $844,836 - $1.24 Million
11,389 New
11,389 $1.18 Million

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $14.7B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Uss Investment Management LTD Portfolio

Follow Uss Investment Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Uss Investment Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Uss Investment Management LTD with notifications on news.